BRIEF INTERVENTION IN AT-RISK FIRST-TIME MOTHERS - 3 - Full Text View

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

BRIEF INTERVENTION IN AT-RISK FIRST-TIME MOTHERS - 3

This study is currently recruiting participants.

Verified by National Institute on Drug Abuse (NIDA), September 2005

First Received: September 29, 2005 No Changes Posted

Sponsored by:	National Institute on Drug Abuse (NIDA)
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00230009

Purpose

Preliminary controlled trial of a brief intervention designed to reduce child maltreatment risk among low-SES pregnant mothers. Foci will include major risk factors for maltreatment, including substance abuse, social isolation, depression, violence exposure, and maladaptive child-rearing attitudes/beliefs.

Condition	Intervention	Phase
Behavior Therapy	Behavioral: Behavior Therapy	Phase I

MedlinePlus related topics: Depression

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention
Official Title:	Clinical Trial

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Depression
Drug and alcohol use
Child Abuse Potential
Treatment engagement
Social Support
Violence exposure

Estimated Enrollment:	100
Study Start Date:	April 2004

Eligibility

Ages Eligible for Study:	18 Years to 45 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Pregnant, expecting first child

Inclusion Criteria:

Receipt of public assistance (e.g., Medicaid, Food Stamps), ability to communicate in English

Exclusion Criteria:

Frank psychosis or other cognitive impairment

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00230009

Contacts

Contact: Steven J Ondersma, Ph.D.

(313)577-6680

s.ondersma@wayne.edu

Locations

United States, Michigan
Wayne State University	Recruiting
Detroit, Michigan, United States, 48207
Contact: Steven J Ondersma, Ph.D. 313-577-6680 s.ondersma@wayne.edu

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

Principal Investigator:

Steven J Ondersma, Ph.D.

Wayne State University

More Information

Publications:

Delaney-Black V, Covington C, Ondersma SJ, Nordstrom-Klee B, Templin T, Ager J, Janisse J, Sokol RJ. Violence exposure, trauma, and IQ and/or reading deficits among urban children. Arch Pediatr Adolesc Med. 2002 Mar;156(3):280-5.

Ondersma SJ, Chaffin MJ, Mullins SM, LeBreton JM. A brief form of the child abuse potential inventory: development and validation. J Clin Child Adolesc Psychol. 2005 Jun;34(2):301-11.

Mullins SM, Bard DE, Ondersma SJ. Comprehensive services for mothers of drug-exposed infants: relations between program participation and subsequent child protective services reports. Child Maltreat. 2005 Feb;10(1):72-81.

Mullins SM, Suarez M, Ondersma SJ, Page MC. The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat. 2004 Jul;27(1):51-8.

Study ID Numbers:	NIDA-00516-3, K23-00516-3
Study First Received:	September 29, 2005
Last Updated:	September 29, 2005
ClinicalTrials.gov Identifier:	NCT00230009 History of Changes
Health Authority:	United States: Federal Government

ClinicalTrials.gov processed this record on May 07, 2009